Skip to main content
Michael Borowitz, MD, Pathology, Baltimore, MD

MichaelJosephBorowitzMD

Pathology • Baltimore, MD

Anatomic Pathology, Clinical Pathology

Professor of Pathology, Professor of Oncology, Johns Hopkins University School of Medicine; Director, Division of Hematologic Pathology, Co-director, Genes to Society, Deputy Director, Education, Department of Pathology, Deputy Director, Clinical Affairs, Department of Pathology

Join to view full profile

Dr. Borowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Borowitz's full profile

Already have an account?

  • Office

    1800 Orleans St.
    Sheikh Zayed Tower
    Baltimore, MD 21287
    Phone+1 410-955-9790

Summary

  • Dr. Michael Borowitz is a pathologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He received his medical degree from Duke University School of Medicine and has been in practice 40 years. He specializes in hematopathology.

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1977 - 1981
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1977

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2015 - 2024
  • MD State Medical License
    MD State Medical License 1993 - 2024
  • FL State Medical License
    FL State Medical License 2015 - 2017
  • NC State Medical License
    NC State Medical License 1977 - 2002
  • American Board of Pathology Anatomic Pathology & Clinical Pathology

Publications & Presentations

PubMed

Journal Articles

  • Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children's Oncology Group  
    Michael J Borowitz, Nyla A Heerema, Brent L Wood, Elizabeth A Raetz, Stephen P Hunger, Andrew J Carroll, Mignon L Loh, Cheryl L Willman, Kelly W Maloney, Blood
  • Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic Leukaemia  
    Michael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature

Abstracts/Posters

  • A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...
    Michael J. Borowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631...
    Michael J. Borowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Outcome in Adolescent and Young Adult (AYA) Patients Compared to Younger Patients Treated for High-Risk B-Lymphoblastic Leukemia (HR B-ALL): Report from the ChildrenÍs...
    Michael J. Borowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Novel Subtypes in B Progenitor Acute Lymphoblastic Leukemia
    Novel Subtypes in B Progenitor Acute Lymphoblastic LeukemiaDecember 12th, 2018
  • Acute Leukemia Workups, from Top to Bottom
    Acute Leukemia Workups, from Top to BottomMay 17th, 2017

External Links

Dr. Michael Borowitz, Dr. Michael Borowitz, MD, Dr. M Borowitz, Dr. Michael Joseph Borowitz